Peter Nørkjær Laursen, MD

Medical Director

Peter has more than a decade of experience in clinical practice and clinical research. Prior to joining Hemab, Peter worked as medical director in clinical development at Novo Nordisk where he led the design and execution of clinical trials in patients with rare bleeding disorders. Peter earned his MD from Aarhus University and his PhD from University Hospital, Rigshospitalet - University of Copenhagen, and has numerous publications in clinical research.

Meet the Team

Hemab unites experts in clotting, patient care, and drug development to transform the lives of people with bleeding disorders

Leadership
Board
Team
Investors
novo holdings
RA Capital
HealthCap
Access Biotechnology
Deep Track Capital
Avoro Ventures
Invus
Rock Springs Capital
Maj Invest Equity
Hemab team photo
Hemab icon in larger circles

We’re building the ultimate clotting company.